| Balaxi Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532597 |
NSE Symbol : BALAXI |
P/E(TTM) : 26.23 |
|
ISIN Demat : INE618N01022 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.93 |
|
Book Value(₹) : 24.09 |
Market Cap(₹Cr) : 134.65 |
Face Value(₹) : 2.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 20.24 | 24.59 | 19.31 | 16.71 | 9.65 | 11.16 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 20.24 | 24.59 | 19.31 | 16.71 | 9.65 | 11.16 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 3.37 | 1.62 | 4.21 | 0.46 | 0.32 | 2.92 |
| Total Income | 23.61 | 26.22 | 23.52 | 17.17 | 9.97 | 14.07 |
| Total Expenditure | 22.17 | 23.21 | 18.54 | 16.17 | 10.30 | 11.06 |
| PBIDT | 1.44 | 3.01 | 4.99 | 1.00 | -0.33 | 3.01 |
| Interest | 0.71 | 0.73 | 0.62 | 0.63 | 0.69 | 0.57 |
| PBDT | 0.73 | 2.27 | 4.37 | 0.37 | -1.03 | 2.45 |
| Depreciation | 0.31 | 0.15 | 0.12 | 0.11 | 0.11 | 0.11 |
| Tax | -0.21 | 0.59 | 0.99 | 0.08 | 0.08 | 0.61 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.47 | 0.00 | -0.02 | -0.02 | -0.04 | -0.02 |
| Reported Profit After Tax | 0.16 | 1.53 | 3.26 | 0.19 | -1.18 | 1.74 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.16 | 1.53 | 3.26 | 0.19 | -1.18 | 1.74 |
| EPS (Unit Curr.) | 0.03 | 0.28 | 0.59 | 0.04 | -0.21 | 0.32 |
| EPS (Adj) (Unit Curr.) | 0.03 | 0.28 | 0.59 | 0.04 | -0.21 | 0.32 |
| Calculated EPS (Unit Curr.) | 0.03 | 0.28 | 0.59 | 0.04 | -0.21 | 0.32 |
| Calculated EPS (Adj) (Unit Curr.) | 0.03 | 0.28 | 0.59 | 0.04 | -0.21 | 0.32 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.11 | 1.11 | 2.36 | 0.14 | -0.85 | 1.26 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.11 | 1.11 | 2.36 | 0.14 | -0.85 | 1.26 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 11.04 | 11.04 | 11.04 | 11.04 | 11.04 | 11.04 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 7.11 | 12.24 | 25.84 | 5.98 | -3.42 | 26.97 |
| PBDTM(%) | 3.61 | 9.23 | 22.63 | 2.21 | -10.67 | 21.95 |
| PATM(%) | 0.79 | 6.22 | 16.88 | 1.14 | -12.23 | 15.59 |
